New autism clinic opens at Riverton hospital, offering early intervention services
Lily is a 13-year-old Swiftie with dreams of being a singer and actress despite being diagnosed with autism spectrum disorder at a young age.
While she is now a happy, energetic teen, Lily's parents still remember the early challenges she faced with a severe sensory disorder — which can be common among children with autism — that required her to use a feeding tube at just 16 months old. Over the next few years, Lily underwent occupational therapy to overcome her struggles with food and teach her how to eat solids. At around 3 years old, she had her first breakthrough, according to her father, Roger.
"She had a Cheerio. She took a bite of it, and didn't make it to the hole in the Cheerio, but she swallowed it. She got it down. We were super excited," Roger said.
Lily's experience overcoming her struggles through early therapeutic intervention demonstrates the kind of outcomes the new Applied Behavior Analysis Clinic at Primary Children's Hospital in Riverton hopes to make possible for other children with autism.
The clinic, which opened earlier this year, held a celebratory ribbon-cutting on Tuesday. Administrators there say it aims to address the need for more autism services in the area by offering early intervention programs for children ages 2 to 6, such as behavioral assessments, individual therapy and group therapy.
Katie Maday, service line director for Developmental Pediatrics and Autism Services at Intermountain Health, explained that the growing need for these services currently outpaces the number of programs available for children with autism.
"We are currently looking at 1 in 36 children who will be diagnosed with autism nationally, which equates to 25,000 children in Utah alone. That means that the need for services and supports is absolutely staggering compared to the supply of available providers in our service area," she said.
Maday said the focus for her department is to increase capacity, train providers and open new services to meet the demand.
"Meeting demand is so crucial because we know that when we don't have enough supports, our children wait for services that they need to thrive, and that waiting time can impact outcomes," she explained.
Children with autism who receive early intensive behavioral intervention have fewer challenges with communication and severe behaviors and a lower incidence of intellectual disabilities, according to Maday. The new clinic will be part of the effort to expand access to autism diagnostics and early behavioral intervention services that patients need to thrive.
Intermountain Healthcare's Primary Promise campaign raised over $600 million to fund the new autism clinic. During Tuesday's ceremony, the owner and founder of luxury blanket company Minky Couture, Sandi Hendry, announced a $3 million donation to the campaign to support autism services.
Hendry explained that when one of her grandchildren started showing signs of autism at a young age, he was placed on a waitlist for over two years before receiving a diagnosis. She said that personal situation is what motivated her to become part of the effort to expand these services in Utah.
"I started calling people I knew with autism in their family and, through connections with community, we found the best answers (out) of anything. So when I heard ... that IHC and Primary Promise were doing this new facility for autism, I thought: There are thousands of people that need these answers, thousands of moms that lay in waiting to know, 'What's my next step?' So, I am grateful today to be able to donate this portion, and I pray that as I grow as a business woman, that I will be able to continue to contribute."
Through her company, Hendry previously donated $1 million to Intermountain Health's Newborn Intensive Care initiative. Minky Couture has also donated over 50,000 mini-Minky blankets to infants being treated in NICUs throughout the United States.
Lily and her family were also present at the celebratory event. Her parents each shared their gratitude for those who supported the clinic's opening and have been part of helping Lily overcome the difficult aspects of having autism.
Lily presented Hendry and Primary Promise Executive Campaign Cabinet Co-Chairwoman Gail Miller with pieces of her artwork as a token of appreciation for their financial support.
"I just want to thank Gail Miller and Sandi for helping everyone with autism," Lily said. "Some people with autism have friends that treat (them) different because of it, and we all don't know why. But we're not doing anything wrong; we're just trying to find our way. I just want to say thank you to everyone helping us with autism, and I can't wait to see what you do in the future to help people with disabilities."
While the new clinic is a noteworthy step in helping more families in Riverton and surrounding areas, there is still a need for these services in many Utah communities, according to Maday. This need includes children with autism who demonstrate severe or aggressive behaviors, like self-injury, and require help from a specialized team of professionals.
"We know to be able to meet the capacity needs of the community, we need to expand our diagnostic services so we can get kids diagnosed sooner and into therapy sooner. We also need to expand our early behavioral intervention services," Maday said. "We are (also) looking to expand or establish severe behavior services in Intermountain's geography in Utah. Severe behavior services are very lacking in our geography right now. We have about one location for the whole state, and there's so much need."
For more information on how to support the Primary Promise initiative to expand autism services, visit its website.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Miami Herald
an hour ago
- Miami Herald
Puppy abandoned after being diagnosed with deadly disease – but she's a fighter
When humans hear the word 'parvo,' which is an infection known as canine parvovirus, come out of the mouths of their veterinarians, it can cause panic. The virus, which is extremely contagious, attacks 'white blood cells and the gastrointestinal tract of dogs' and in puppies 'can damage the heart muscle,' the American Veterinary Medical Association says. So when a puppy named Lily was diagnosed in a Chicago emergency vet, hope waned. 'A parvovirus diagnosis is the last thing you want to hear as a pet owner. It's deadly, highly contagious, and very expensive to treat, for a pet owner or a shelter,' the PAWSChicago shelter said in a June 5 Instagram post. 'After Lily was admitted to an emergency vet clinic, her owner wouldn't come back for her. Things are hard right now. Pet surrenders are up 312% at CACC, many of them because people are struggling to afford the cost of basic pet care, let alone major medical costs.' Thankfully, the shelter was able to take the sweet girl in. In the video posted to social media, Lily is a spunky girl with large eyes and a boopable nose. 'But Lily can't live at the emergency clinic, and she needed someplace to go. Earlier this week, she came to PAWS to continue her treatment. While she hasn't beat parvo yet, she's doing really well so far!' the shelter said. To keep up with Lily's story, follow the shelter's Instagram.
Yahoo
4 days ago
- Yahoo
Intermountain Health launches cancer treatment program for patients with advanced melanoma skin cancer
SALT LAKE CITY, Utah (ABC4 Utah) – May is Melanoma Awareness Month and Intermountain Health is unveiling an exciting new treatment program for Utahns with advanced melanoma cancer – the first time local patients have been treated with this advanced technology and new therapy in the Beehive State. Thanks to this new cutting-edge personalized cancer treatment program, Utahns who have advanced melanoma cancer no longer have to leave the state to get a groundbreaking new treatment that is showing promise for patients with the deadliest type of skin cancer. Intermountain Health has launched a new program to provide tumor-infiltrating lymphocyte (TIL) therapy to treat patients with a type of skin cancer called unresectable or metastatic melanoma that cannot be removed surgically or has spread to other parts of the body. It is the first time this therapy has been used to treat patients in Utah. This novel therapy works by using special immune cells, called lymphocytes, which are taken from the tumor itself. These cells are then multiplied in a lab and put back into the patient's body to help fight the cancer. As part of the treatment process, doctors use AMTAGVI, the first and only FDA-approved prescription medication for the treatment of advanced melanoma that has not responded to standard therapies. AMTAGVI activates the patient's own immune system to target and destroy cancer cells and represents a different approach compared to other immunotherapies. Instead of broadly stimulating the immune system, it harnesses a patient's own tumor-specific T cells to directly target and destroy cancer cells. Intermountain Health cancer experts say the groundbreaking treatment marks a significant advancement in the fight against advanced melanoma, offering a new option for patients with limited treatment alternatives. 'We're excited to offer this advanced therapy and the hope it provides for improved outcomes for patients who have not responded to standard therapies,' said Tawnya Bowles, MD, a surgical oncologist at Intermountain Health. 'The promise for patients is that this treatment will work against their advanced melanoma when other treatments have failed. These patients do not have as many treatment options once their tumor has progressed on standard treatments. This therapy offers new hope for these patients.' TIL therapy has been used for decades, but AMTAGVI allows the treatment to extend beyond select treatment centers by using a protocol that lets a patient's tumor T cells grow at centralized facilities in the United States. Previously, only limited academic facilities with lab facilities could grow and expand the T cells. For Utahns, having the therapy program available locally is a major advancement. Not only does Utah have the highest incidence of melanoma in the nation, but until now, Utahns needing TIL therapy had to travel out of state for their care. 'Each year we see Utah patients who need this next step of treatment for advanced melanoma, and these patients previously had to leave the state and incur the expense of travel and the increased stress of being away from home,' said Caroline Nebhan, MD, PhD, Intermountain Health medical oncologist. 'We're thrilled to be able to offer this advanced treatment close to home with our Intermountain Health oncology team.' Patients in the new Intermountain treatment program are supported by a multi-disciplinary team of clinicians, including oncology experts and patient navigators, who work closely with patients throughout their treatment. The therapy involves surgically removing a sample of the patient's tumor, from which tumor-infiltrating lymphocytes (TILs) are extracted. These TILs, which are immune cells capable of recognizing and attacking cancer cells, are then sent to a specialized manufacturing facility where they are expanded and multiplied into billions of cells. Once the manufacturing process is complete (approximately 34 days), the patient undergoes a short course of lymphodepleting chemotherapy to prepare their body for the infusion of the expanded TILs. Following the AMTAGVI infusion, patients may receive several doses of interleukin-2 (IL-2) to further stimulate the activity and growth of the infused T cells. Patients are cared for in the hospital for a period to monitor for potential side effects. Research results of the medication were promising. Clinical trial data supporting FDA approval of AMTAGVI demonstrated promising response rates and, in many cases, prolonged outcomes in patients with advanced melanoma, suggesting the potential for long-term control of the disease. 'We're committed to providing our patients with access to the most advanced and innovative cancer treatments,' said Dr. Bowles. 'The addition of AMTAGVI to our comprehensive oncology program underscores this commitment and offers new hope for patients battling advanced melanoma.' To learn more about cancer care at Intermountain Health, go to Close Thanks for signing up! Watch for us in your inbox. Subscribe Now Sponsored by Intermountain Health. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Yahoo
5 days ago
- Yahoo
Inspire Autism Names Kristin Hustyi, MA, BCBA as Chief Clinical Officer, Strengthening Its Position as a Leader in Autism Therapy Services
DETROIT, June 5, 2025 /PRNewswire/ -- Inspire Autism, a growing provider of evidence-based therapy for children diagnosed with autism spectrum disorder, announces the appointment of Kristin M. Hustyi, MA, BCBA, as its new Chief Clinical Officer. This strategic addition highlights Inspire Autism's commitment to delivering exceptional outcomes to families across Metro Detroit. Kristin Hustyi brings over 15 years of experience in behavior analysis, clinical innovation, and research leadership to Inspire Autism. She holds a Master of Arts in Applied Behavior Analysis from the University of the Pacific and a Bachelor of Science in Psychology from Western Michigan University. Previously, Hustyi served as Vice President of Research at LittleStar ABA Therapy and National Director of Outcomes at Invo Healthcare. She currently serves as an Adjunct Lecturer at Stanford University School of Medicine. Her clinical work is backed by more than 20 peer-reviewed publications and over 50 national presentations, positioning her as a leading voice in the field. "Inspire Autism has always been dedicated to building a team that delivers high-quality, compassionate, and results-driven care," said Brandon Boudreau, CEO of Inspire Autism. "Kristin's appointment underscores that mission. Her unique blend of clinical experience, research excellence, and thought leadership will be instrumental in elevating the standard of care we offer families." Hustyi will lead Inspire Autism's clinical vision, ensuring the delivery of data-driven therapy rooted in the latest advancements in the field. She will focus on client outcomes, clinician mentorship, and interdisciplinary collaboration with diagnostic professionals and pediatricians throughout Southeast Michigan. "I'm honored to join Inspire Autism at such a pivotal moment in its growth," said Hustyi. "This organization is deeply committed to families, and I look forward to expanding access to individualized services that change lives." Inspire Autism provides early intervention services including Applied Behavior Analysis (ABA), speech therapy, and occupational therapy to children across the autism spectrum. With Kristin Hustyi at the clinical helm, Inspire Autism aims to expand its regional impact and strengthen partnerships with pediatric providers, diagnostic centers, and local communities. About Inspire AutismInspire Autism is an autism spectrum disorder therapy provider specializing in comprehensive services for children. The organization focuses on data-informed outcomes to ensure every child has the opportunity to thrive. Contact:Inspire Autisminfo@ (844) - View original content to download multimedia: SOURCE INSPIRE AUTISM LLC Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
